Latest News and Press Releases

AEON Biopharma Announces First Closing of PIPE Investment and Provides Update on FDA Type 2a Meeting Scheduling

AEON Biopharma Reports Third Quarter 2025 Results, Including Positive ABP-450 Biosimilarity Data and Strategic Positioning for Continued Growth

AEON Biopharma Reports Positive and Robust Biosimilarity Results: Identical Amino Acid Sequence and Highly Similar Functional Analysis Data

AEON Biopharma Announces Fundraise Totaling Up to ~$22 Million through Private Placement and Proposed Exchange of Daewoong Convertible Notes

AEON Biopharma Announces FDA BPD Type 2a Meeting for ABP-450 on November 19

AEON Biopharma Reports Second Quarter 2025 Financial Results and Provides Corporate Update

PALO ALTO, Calif., Nov. 16, 2024 (GLOBE NEWSWIRE) -- The Web3 University Tour series, hosted by AEON and OnePiece Labs in Q4 2024, is a groundbreaking initiative connecting students with the...

Pompano Beach, Fl., March 25, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a pre-clinical-stage biotechnology company focused on harnessing...

Richfield, Minn., Oct. 08, 2020 (GLOBE NEWSWIRE) -- Aeon, a nonprofit developer and operator in the Twin Cities, The Community Development Trust (“CDT”), a national investor in affordable housing,...

Minneapolis, Sept. 21, 2017 (GLOBE NEWSWIRE) -- State Housing Commissioner Mary Tingerthal today announced that more than 400 low-income families, including approximately 200 preschool children...